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Abstract Staphylococcus aureus (S. aureus) colonizes the
anterior nares in part of the population and the persistent
carrier state is associated with increased infection risk.
Knowledge concerning the determinants of S. aureus nasal
carriage is limited. Previously, we found that glucocorticoid
receptor polymorphisms influence carrier risk, suggesting
involvement of glucocorticoids. Our aim was to study
long-term cortisol levels in non-carriers, intermittent, and
persistent carriers of S. aureus. We hypothesized that
cortisol levels are higher in carriers, since cortisol-induced
immune suppression would enhance S. aureus colonization.
We determined nasal carrier state and long-term hair cortisol
levels in 72 healthy subjects. Nasal swabs were collected
twice with an interval of 2 weeks. Cortisol levels were
determined in hair segments of 3 cm, which corresponds to a
period of roughly 3 months. Of all 72 participants, 38 were
non-carriers, 10 were intermittent carriers, and 24 were
persistent carriers of S. aureus. Cortisol levels did not differ
between these carrier groups (p=0.638). Long-term cortisol
levels are not associated with S. aureus nasal carriage.
Introduction
Staphylococcus aureus (S. aureus) can colonize the skin
and mucosae of humans and is most frequently located in
the anterior nares [1]. Carriage of this pathogen is a major
risk in the development of various S. aureus infections [2].
Worldwide, the prevalence of meticillin-resistant strains is
increasing (MRSA). Therefore, it is important to know why
some people are more vulnerable to S. aureus colonization
and what determines the carrier state. Historically, three
patterns of carriage are recognized in humans: persistent
carriage, intermittent carriage, and no carriage. Persistent
carriers have a higher risk of developing S. aureus
infections and the density of the colonization is higher
compared with intermittent carriers [3]. Furthermore,
persistent carriers are usually colonized by one specific
strain, while intermittent carriers may switch strains over
time [4]. However, recently we found that intermittent and
non-carriers share similar S. aureus nasal elimination
kinetics and antistaphylococcal antibody profiles, suggest-
ing that there might be only two types of nasal carriers,
namely persistent carriers and others [5].
The pathogenesis of the nasal colonization of S. aureus
is not completely understood. Host characteristics of the
immune system seem to play a role in determining carrier
status, as well as environmental and humoral factors in
nasal secretions [2]. Another factor that seems to influence
carrier status is glucocorticoid (GC) sensitivity. Polymor-
phisms of the glucocorticoid receptor gene, which are
associated with differences in GC sensitivity, have been
associated with the S. aureus carrier state [6]. Homozygous
carriers of the 9β polymorphism (rs6198), which is
associated with a relative GC resistance with respect to
transrepressional effects, had a 68% decreased risk of
persistent nasal carriage. In contrast, subjects with an
ER22/23EK+9β (rs6189+rs6190 and rs6198) polymor-
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particular with respect to the negative feedback mechanism
and in various tissues, showed an 80% increased risk of being
persistent carriers. The main glucocorticoid in humans is
cortisol. Since cortisol is capable of suppressing the immune
system and polymorphisms affecting GC sensitivity seem to
influence the carriage state of S. aureus, long-term cortisol
levels may differ between the different carrier states.
In this study we determined cortisol levels in scalp hair
to measure long-term cortisol levels. Measurement of
cortisol in scalp hair is a recently developed method of
measuring long-term cortisol levels [7–11]. The important
advantage of this type of cortisol measurement is that there
are no limitations caused by the pulsatile secretion of
cortisol, the circadian rhythm of cortisol secretion and the
variability due to acute circumstances (e.g. physical or
emotional stress). Hair grows at approximately 1 cm per
month [12]; therefore, 1 cm of hair represents the cortisol
level in 1 month. Previous studies showed that endogenous
cortisol can be measured reliably in scalp hair [7–11]. We
hypothesize that higher cortisol levels in hair are associated
with persistent nasal carriage of S. aureus.
Materials and methods
Study population
Eighty healthy individuals participated in this study. All
subjects filled out a questionnaire regarding gender, age, the
u s eo fh a i rp r o d u c t s ,h a i rt r eatment (perm, coloring,
bleaching), and medical status (autoimmune disease and
glucocorticoid use). Participants were excluded if they had
used glucocorticoids during the last 3 months or had an
autoimmune disease. The study was approved by the
Medical Ethics committee of the Erasmus Medical Center
and all participants gave informed consent.
Nasal carriage of S. aureus
Nasal swabs were collected twice at an interval of 2 weeks
and were analyzed as previously described [3]. Subjects
were defined as persistent carriers when both cultures were
positive, intermittent carriers when one of the cultures was
positive and non-carriers when none of the cultures was
positive for S. aureus.
Hair collection and preparation
From all participants, approximately 100 hairs were cut
from the posterior vertex. The 3 cm proximal to the scalp
was used for analysis. Since hair grows at an average rate of
1 cm per month, this corresponds roughly to cortisol levels
in the last 3 months. A detailed description of hair
preparation has been given by Sauvé et al. [9]. In brief,
the 3-cm hair segment was weighted and cut into small
pieces in a glass vial with surgical scissors. One milliliter of
methanol was added and the vial was incubated for 16 h
overnight at 52°C, while gently shaking. The methanol was
then transferred into a glass tube and evaporated under
nitrogen. When dry, the samples were dissolved in 250 μL
phosphate buffered saline (pH 8.0) and vortexed for 1 min
followed by a 30-s vortex before analysis.
Hair analysis
Cortisol levels were measured using a commercially available
ELISA Kit for Salivary Cortisol (DRG International, USA) as
per the manufacturer’s directions with the reagents provided.
Cross reactivity of other steroids with the kit’sa n t i b o d i e sw a s
reported as follows: corticosterone (29.00%), cortisone
(3.00%), 11-deoxycortisol (<1.00%), 17-OH progesterone
(<0.50%), and other hormones (<0.10%). Intra-assay
variation was below 5% and the inter-assay variation
below 8%, as stated by the manufacturer.
Statistical analysis
Statistical analyses were performed using SPSS 17.0 for
Windows (SPSS, Chicago, IL, USA). Differences in
baseline characteristics between the different carrier state
groups were tested using Chi-squared tests and ANOVA.
Cortisol levels were log transformed to obtain a normal
distribution. ANOVA was used to test the effects of gender,
hair treatment, and the use of hair products on cortisol
levels. With an ANCOVA the relationship between cortisol
levels and the S. aureus carrier state was tested, while
controlling for gender, age, and hair treatment.
Results
After exclusion of subjects who used glucocorticoids in the
last 3 months or who had an autoimmune disease, 72
individuals were analyzed. Carrier group characteristics are
presented in Table 1. There were no significant differences
in group characteristics.
After log transformation, hair cortisol levels were
normally distributed (Kolmogorov–Smirnov p=0.200).
Hair cortisol levels were significantly lower in the hair
treatment group compared with the untreated hair group
(23.77 pg/mg hair versus 33.42 pg/mg hair, F(1,70)=8.295,
p=0.005). No significant effects of gender F(1,70)=2.428,
p=0.124) or use of hair product (F(1,69)=0.106, p=0.746)
on cortisol levels was found. There was no correlation
between age and hair cortisol (rs=−0.028, p=0.816).
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s h o w ni nF i g .1. Hair cortisol levels did not significantly
differ in the last 3 months between carrier groups
(F(2,66)=0.425, p=0.638, corrected for hair treatment,
age, and gender). In addition, cortisol levels in the
combined group of non-carriers and intermittent carriers
were not significantly different from cortisol levels in
persistent carriers (F(1,67)=0.837, p=0.363).
Discussion
Our study shows that there are no differences in long-term
cortisol levels, as measured in scalp hair, among non-carriers,
intermittentcarriers,andpersistentcarriersofS. aureus.T oo u r
knowledge, this is the first study that determined hair cortisol
levels with regard to the nasal carriage status of S. aureus.
Measurement of cortisol in scalp hair is a recently developed
method of measuring long-term cortisol levels and seems a
reliable measure of long-term cortisol exposure, as shown in
several other studies [7–11]. Higher cortisol levels during a
longer period of time could lead to an immunosuppressive
effect and subsequently to increased S. aureus colonization.
Theoretically, higher cortisol levels in scalp hair could be
associated with persistent nasal carriage of S. aureus.
However, in the present study we did not observe chronically
higher cortisol levels in persistent nasal S. aureus carriers.
Interestingly, polymorphisms in the glucocorticoid
receptor gene seemed to influence the carrier state of S.
aureus. We previously showed that the 9β polymorphism
was associated with a 68% decreased risk of S. aureus
carriage [6]. This polymorphism is thought to increase the
stability of the GR-β isoform, which is a dominant
negative inhibitor of the active GR-α, and therefore
causes a relative GC resistance. This relative resistance
could lead to decreased suppression of the immune system
by GCs, which would result in a more active immune
system, yielding a decreased risk of S. aureus coloniza-
tion. This was indeed the main finding of that study.
Furthermore, the ER22/23EK polymorphism of the GR
gene was found to be associated with an increased risk of
S. aureus carriage. The ER22/23EK polymorphism is
associated with a relative resistance for GCs for its
transactivating effect, but this polymorphism may not
affect the immune system since normal transinhibition of
the proinflammatory nuclear factor NF-κB was observed
[13]. Although numerous effects throughout the body
have been reported for all these GR polymorphisms, no
differences in serum cortisol levels have been described
[14], suggesting that the mildly altered GC sensitivity is
mostly present at the tissue level with a potential cell-specific
effect. Since GR polymorphisms only slightly affect GC
sensitivity with respect to the negative feedback
mechanism, no evident differences in cortisol levels
may be observed. This would explain why we did not
find any differences in long-term cortisol levels between
carrier states despite the fact that there was a clear effect
of GR polymorphisms. In our study population, GR
polymorphisms were not determined; therefore, an
interaction between long-term cortisol levels and GR
polymorphisms could not be studied.
Since cortisol levels seem not to significantly influence
the risk of S. aureus colonization, it is possible that genetics
and other host factors are more important. This is also
supported by the finding that non-carriers, when inoculated
with different S. aureus strains, quickly become non-
carriers again, while persistent carriers select the strain they
were carrying before [15]. These findings suggest that
individuals are quite stable regarding their carrier state.
Fig. 1 Mean cortisol levels in the carrier groups. Error bars represent
SEM
Table 1 Group characteristics
Non-carriers, n=38 Intermittent carriers, n=10 Persistent carriers, n=24 p value
Age, years (range) 35.42 (21–60) 41.00 (22–58) 33.71 (19–55) 0.272
Gender, women (%) 24 (63.2) 6 (60) 13 (54.2) 0.781
Hair treatment (%) 8 (21.1) 3 (30) 8 (33.3) 0.543
Use of hair products (%) 17 (44.7) 8 (80) 8 (34.8) 0.054
Data are shown as number (%). Age is shown as mean (minimum to maximum). Hair treatment includes dyeing, bleaching and permanent
waving. Hair products used were spray, mousse, gel, and wax
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or physical stress and are therefore not necessarily stable
and possibly a less important host factor for S. aureus
colonization. Nevertheless, we cannot rule out that cortisol
may indirectly play a role in S. aureus colonization by
interacting with host factors of the immune system and an
individual’s genetic make-up. Interestingly, persistent S.
aureus colonization does not seem to lead to greater
physical stress since cortisol levels would then be increased
in persistent carriers.
In conclusion, we found no differences in long-term
cortisol levels, measured in scalp hair, among non-carriers,
intermittent carriers, and persistent carriers of S. aureus
in the anterior nares. Thus, cortisol levels seem not to
significantly affect the carriage state of S. aureus.
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